LNP Formulation Equipment Market
完整報告名稱與涵蓋範圍
LNP Formulation Equipment Market Size, Share & Trends Analysis Report, By Equipment Type (Microfluidic Mixing Systems, Impingement Jet and T-Mixer Systems, Extrusion, Homogenization and Auxiliary Formulation Equipment, Process Control and Single-Use Fluid Path Consumables), By Scale (Research and Discovery Scale, Clinical and Pilot Scale, Commercial Manufacturing Scale), By Application (mRNA Vaccines and Therapeutics, siRNA and Oligonucleotide Therapeutics, Gene Editing and Cell Therapy Delivery, Liposomal Small-Molecule Drugs), By End User, By Region, and Segment Forecasts, 2026-2035
報告摘要
The LNP formulation equipment market covers instruments and systems used to produce lipid nanoparticles and liposomes, including microfluidic mixers, impingement jet and T-mixer systems, extrusion and homogenization equipment, process control units and the single-use fluid paths and cartridges they consume, from discovery scale to commercial manufacturing. Formulation services, lipid raw materials and downstream tangential flow filtration systems are excluded.
Investment is driven by the expansion of RNA and gene-editing pipelines, by the need to reproduce particle size and encapsulation efficiency consistently from benchtop screening through GMP production and by the preference of manufacturers for closed, single-use systems that simplify validation. Microfluidic platforms dominate discovery and early clinical work because they allow rapid formulation screening with milligram quantities, while impingement jet and multi-inlet vortex mixers scale to litre-per-minute throughput for commercial supply. Vendors are adding in-line particle analytics, automated recipe management and scale-equivalent cartridge families that preserve mixing conditions across scales, and formulation scientists increasingly evaluate equipment on lipid-agnostic performance and intellectual property freedom.
North America and Europe lead purchases, with China, Japan and South Korea expanding equipment installations alongside domestic RNA manufacturing. Competition involves bioprocess groups that acquired microfluidic pioneers, specialist mixer and microfluidics companies and laboratory instrument makers.
The InsightAce study supplies US$ forecasts for all equipment type, scale, application and end user and regional segments over 2026-2035, segment-level trend analysis, competitive landscape assessment and profiling of the leading companies.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global LNP Formulation Equipment Market Snapshot
Chapter 4. Global LNP Formulation Equipment Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Equipment Type Estimates & Trend Analysis
5.1. Equipment Type & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Equipment Type:
5.2.1. Microfluidic Mixing Systems
5.2.2. Impingement Jet and T-Mixer Systems
5.2.3. Extrusion, Homogenization and Auxiliary Formulation Equipment
5.2.4. Process Control and Single-Use Fluid Path Consumables
Chapter 6. Market Segmentation 2: By Scale Estimates & Trend Analysis
6.1. Scale & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Scale:
6.2.1. Research and Discovery Scale
6.2.2. Clinical and Pilot Scale
6.2.3. Commercial Manufacturing Scale
Chapter 7. Market Segmentation 3: By Application Estimates & Trend Analysis
7.1. Application & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Application:
7.2.1. mRNA Vaccines and Therapeutics
7.2.2. siRNA and Oligonucleotide Therapeutics
7.2.3. Gene Editing and Cell Therapy Delivery
7.2.4. Liposomal Small-Molecule Drugs
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. End User & Market Share, 2026 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by End User:
8.2.1. Pharmaceutical and Biotechnology Companies
8.2.2. CDMOs
8.2.3. Academic and Research Institutes
Chapter 9. LNP Formulation Equipment Market: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. United States
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. South Korea
9.3.5. Australia
9.3.6. Southeast Asia
9.3.7. Rest of Asia Pacific
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Middle East & Africa
9.5.1. GCC Countries
9.5.2. South Africa
9.5.3. Rest of Middle East & Africa
Chapter 10. Competitive Landscape
10.1. Company Market Positioning Analysis
10.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 11. Company Profiles
11.1. Cytiva (Danaher) (Precision NanoSystems)
11.2. Micropore Technologies Ltd.
11.3. KNAUER Wissenschaftliche Gerate GmbH
11.4. Inside Therapeutics
11.5. PreciGenome LLC
11.6. DIANT Pharma Inc.
11.7. Sartorius AG
11.8. Thermo Fisher Scientific Inc.
11.9. Dolomite Microfluidics (Blacktrace)
11.10. Helix Biotech, Inc.
11.11. Unchained Labs
11.12. Evonik Industries AG (Formulation Services)
11.13. Malvern Panalytical Ltd.
11.14. Avestin Inc.
11.15. Microfluidics International Corporation (IDEX)
圖表清單 List of Tables & Figures
Table 1. Global LNP Formulation Equipment Market Revenue Forecast by Equipment Type, 2026-2035 (US$ Mn)
Figure 1. Global LNP Formulation Equipment Market Segmentation Overview
Table 2. Global LNP Formulation Equipment Market Revenue Forecast by Scale, 2026-2035 (US$ Mn)
Figure 2. Global LNP Formulation Equipment Market Share by Equipment Type, 2026 & 2035
Table 3. Global LNP Formulation Equipment Market Revenue Forecast by Application, 2026-2035 (US$ Mn)
Figure 3. Nanoparticle Mixing Technology Comparison Across Scales: Microfluidic, Impingement Jet and Vortex Mixers
Table 4. Global LNP Formulation Equipment Market Revenue Forecast by End User, 2026-2035 (US$ Mn)
Figure 4. Global LNP Formulation Equipment Market Share by Scale, 2026 & 2035
Table 5. North America LNP Formulation Equipment Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 5. Installed Base Growth of LNP Formulation Systems by Scale and Region, 2026-2035
Table 6. Europe LNP Formulation Equipment Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 6. Asia Pacific LNP Formulation Equipment Growth Opportunity Analysis
Table 7. Asia Pacific LNP Formulation Equipment Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 7. Scale-Equivalent Cartridge and Fluid Path Strategies for Technology Transfer
Table 8. Latin America LNP Formulation Equipment Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 8. Competitive Positioning of Key LNP Formulation Equipment Market Participants
Table 9. Middle East & Africa LNP Formulation Equipment Market Revenue by Country, 2026-2035 (US$ Mn)
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們